loadpatents
name:-0.018465042114258
name:-0.011974811553955
name:-0.0017170906066895
KALLEN; Joerg Patent Filings

KALLEN; Joerg

Patent Applications and Registrations

Patent applications and USPTO patent grants for KALLEN; Joerg.The latest application filed is for "biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors".

Company Profile
0.17.23
  • KALLEN; Joerg - Basel CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Biaryl Derivatives As Yap/taz-tead Protein-protein Interaction Inhibitors
App 20210299100 - BORDAS; Vincent ;   et al.
2021-09-30
Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
Grant 9,670,193 - Hebach , et al. June 6, 2
2017-06-06
Pyrazolo[3,4-d]pyrimidinone compounds as inhibitors of the P53/MDM2 interaction
Grant 9,556,180 - Furet , et al. January 31, 2
2017-01-31
Substituted purinone compounds
Grant 9,403,827 - Furet , et al. August 2, 2
2016-08-02
Pyrrolopyrrolidinone compounds
Grant 9,365,576 - Cotesta , et al. June 14, 2
2016-06-14
Substituted Purinone Compounds
App 20150353551 - FURET; Pascal ;   et al.
2015-12-10
Pyrazolo[3,4-d]pyrimidinone Compounds As Inhibitors Of The P53/mdm2 Interaction
App 20150353563 - FURET; Pascal ;   et al.
2015-12-10
Trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
Grant 9,056,843 - Hebach , et al. June 16, 2
2015-06-16
Substituted isoquinolinones and quinazolinones
Grant 9,051,279 - Berghausen , et al. June 9, 2
2015-06-09
Imidazopyrrolidinone Compounds
App 20140343084 - FURET; Pascal ;   et al.
2014-11-20
Novel Trifluoromethyl-oxadiazole Derivatives And Their Use In The Treatment Of Disease
App 20140329825 - Hebach; Christina ;   et al.
2014-11-06
Hydroxy substituted isoquinolinone derivatives
Grant 8,859,535 - Buschmann , et al. October 14, 2
2014-10-14
Cyclohexyl isoquinolinone compounds
Grant 8,859,586 - Furet , et al. October 14, 2
2014-10-14
Cyclohexyl Isoquinolinone Compounds
App 20140275158 - Furet; Pascal ;   et al.
2014-09-18
Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases
Grant 8,815,926 - Furet , et al. August 26, 2
2014-08-26
Novel Trifluoromethyl-oxadiazole Derivatives And Their Use In The Treatment Of Disease
App 20140142105 - Hebach; Christina ;   et al.
2014-05-22
Hdyroxy Substituted Isoquinolinone Derivatives
App 20140135306 - Buschmann; Nicole ;   et al.
2014-05-15
Use of 1H-Quinazoline-2,4-Diones
App 20140018376 - Allgeier; Hans ;   et al.
2014-01-16
Imidazopyrrolidinone Compounds
App 20140011798 - FURET; Pascal ;   et al.
2014-01-09
Pyrrolopyrrolidinone Compounds
App 20130317024 - Cotesta; Simona ;   et al.
2013-11-28
Substituted Isoquinolinones And Quinazolinones
App 20130281473 - BERGHAUSEN; Joerg ;   et al.
2013-10-24
Substituted isoquinolinones and quinazolinones
Grant 8,440,693 - Berghausen , et al. May 14, 2
2013-05-14
Tetra-substituted Heteroaryl Compounds And Their Use As Mdm2 And/or Mdm4 Modulators
App 20120149661 - Bold; Guido ;   et al.
2012-06-14
Substituted Isoquinolinones and Quinazolinones
App 20110230457 - BERGHAUSEN; Joerg ;   et al.
2011-09-22
Mevinolin derivatives
App 20020037895 - Baenteli, Rolf ;   et al.
2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed